Login

Healthcare

00:10:00
Carmat's clinical developments, production capabilities, and financial situation | Stéphane Piat, CEO, Carmat SA.
00:10:00
Advancing Alzheimer's Treatment: CEO Discusses Promising Phase 2 Data and Multi-dimensional Drug Approach | Remi Barbier, CEO, Cassava Sciences Inc.
00:10:00
Harnessing the Power of the Placenta: A Journey in Cellular Medicine Innovation and Preservation of Human Performance| Robert Hariri, M.D., Ph.D., CEO, Celularity Inc.
00:10:00
Unlocking UK's Cannabis Potential: Celadon Pharmaceuticals' Path| James Short , CEO,Celadon Pharmaceuticals PLC.
00:10:00
Exploring Cellectar's Cutting-Edge Cancer Treatment and Biotech Challenges | James V Caruso, CEO,Cellectar Biosciences Inc.
00:10:00
Biotech Innovator Advocates for Collaborative Healthcare Approach | André Choulika, CEO,Cellectis SA.
00:10:00
Innovative Pharmaceuticals: Progress and Prospects Revealed by Industry Leader| Dr Maciej Wieczorek, CEO,Celon Pharma SA.
00:10:00
AI Integration and SPAC Merger: Cellularity CEO Discusses Advances in Cancer Treatment and Lessons from the Pandemic| Robert Hariri, M.D., Ph.D., CEO, Celularity Inc.
00:10:00
Novel Cell Therapy Approaches for Oncology Highlight Manufacturing and Commercialization Strategies at Cell | Filippo Petti, CEO, Celyad Oncology SA.
00:10:00
Insights from a CEO on Educating Physicians and Recognizing Diagnostic Challenges | Dr. Arndt Rolfs, CEO, Centogene NV.
00:10:00
Positive Quarterly Results and Long-Term Goals | Dr Maciej Wieczorek, CEO,Celon Pharma SA.
00:10:00
A Dive into the Transformative Potential of Stem Cells in Enhancing Health and Longevity, as Explored in an In-Depth Discussion| Robert Hariri, M.D., Ph.D., CEO, Celularity Inc.
00:10:00
CEO traces path from undergrad cancer biology interest to oncology biotech leadership | Filippo Petti, CEO, Celyad Oncology SA.
00:10:00
CEO elaborates on global efforts to enhance early diagnosis of rare hereditary diseases and metabolomics approaches to address diverse patient populations | Dr. Arndt Rolfs, CEO, Centogene NV.
00:10:00
The transformative potential of cell therapy for cancer treatment and highlights recent clinical advancements and team expertise | Jennifer Chow, CEO, Chimeric Therapeutics Ltd.
00:10:00
CEO discusses UK supermarket deal and revenue growth, highlighting shift to nicotine-free vape products and expansion plans for 2024 | Callum Sommerton, CEO, Chill Brands Group PLC.

© 2026 Nehu